Lisa A. Lewis

Holistic Medicine
626 Frederick St
Santa Cruz, CA 95062

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenB.

Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenB.

Journal: NPJ vaccines
Published: January 13, 2026

The gonococcal vaccine candidate antigen NGO1701 is a N. gonorrhoeae periplasmic copper storage protein.

The gonococcal vaccine candidate antigen NGO1701 is a N. gonorrhoeae periplasmic copper storage protein.

Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025

The gonococcal vaccine candidate antigen NGO1701 is a N. gonorrhoeae periplasmic copper storage protein.

The gonococcal vaccine candidate antigen NGO1701 is a N. gonorrhoeae periplasmic copper storage protein.

Journal: PLoS pathogens
Published: March 20, 2025

Preclinical efficacy of a cell division protein candidate gonococcal vaccine identified by artificial intelligence.

Preclinical efficacy of a cell division protein candidate gonococcal vaccine identified by artificial intelligence.

Journal: mBio
Published: October 31, 2023

Alternative pathway amplification and infections.

Alternative pathway amplification and infections.

Journal: Immunological reviews
Published: November 07, 2022

An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae.

An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae.

Journal: Frontiers in immunology
Published: June 22, 2022

Neisseria gonorrhoeae Infection in Women Increases With Rising Gonococcal Burdens in Partners: Chlamydia Coinfection in Women Increases Gonococcal Burden.

Neisseria gonorrhoeae Infection in Women Increases With Rising Gonococcal Burdens in Partners: Chlamydia Coinfection in Women Increases Gonococcal Burden.

Journal: The Journal of infectious diseases
Published: May 28, 2022

Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal Complement.

Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal Complement.

Journal: The Journal of infectious diseases
Published: February 08, 2021

Efficacy of Antigonococcal CMP-Nonulosonate Therapeutics Require Cathelicidins.

Efficacy of Antigonococcal CMP-Nonulosonate Therapeutics Require Cathelicidins.

Journal: The Journal of infectious diseases
Published: June 10, 2020

Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms.

Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms.

Journal: FEBS letters
Published: January 05, 2020

Therapeutic CMP-Nonulosonates against Multidrug-Resistant Neisseria gonorrhoeae.

Therapeutic CMP-Nonulosonates against Multidrug-Resistant Neisseria gonorrhoeae.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 22, 2019

A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.

A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.

Journal: mBio
Published: June 20, 2019
Showing 1-12 of 35

Last Updated: 09/26/2026